HPS Pharmacies wish to advise that Fresenius Kabi is experiencing a supply interruption for Ropivacaine Kabi as follows:
Ropivacaine Kabi 0.2%
This short-term supply interruption is expected to resolve by August 2022. This supply interruption only relates to the 200mg/100mL presentation of Ropivacaine Kabi 0.2%. Other presentations and alternative brands of Ropivacaine 0.2% are currently unaffected and is still available at wholesalers.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Fresenius Kabi on (02) 9391 5555 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates